Wellington Management Group
TSHA icon

Wellington Management Group’s Taysha Gene Therapies TSHA Stock Holding History

Wellington Management Group’s Portfolio TSHA Stock Details TSHA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.1M Buy
3,975,605
+3,349,244
+535% +$19.8M ﹤0.01% 945
2026
Q1 		$2.8M Sell
626,361
-84,874
-12% -$395K ﹤0.01% 1500
2025
Q4 		$3.91M Buy
711,235
+143,229
+25% +$696K ﹤0.01% 1454
2025
Q3 		$1.86M Sell
568,006
-67,962
-11% -$192K ﹤0.01% 1651
2025
Q2 		$1.47M Buy
635,968
+10,770
+2% +$23.4K ﹤0.01% 1648
2025
Q1 		$869K Buy
625,198
+39,604
+7% +$66.2K ﹤0.01% 1731
2024
Q4 		$1.01M Buy
585,594
+122,402
+26% +$254K ﹤0.01% 1718
2024
Q3 		$931K Buy
+463,192
New +$1.02M ﹤0.01% 1724
2020
Q4 		– Sell
-16,889
Closed -$378K – 2010
2020
Q3 		$378K Buy
+16,889
New +$397K ﹤0.01% 1766

Other funds holding TSHA

ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group's TSHA Position: Q2 2026 in Review

Wellington Management Group increased its Taysha Gene Therapies (TSHA) stake by 535% in Q2 2026, buying an estimated $19.8M and bringing the position to 3,975,605 shares worth $27.1M. The position accounts for ﹤0.01% of the portfolio, ranked #945.

Wellington Management Group first reported a position in TSHA in Q3 2020 and has held it in 9 quarters since. 209 funds tracked by Wall St. Rank hold TSHA as of Q2 2026.

  • Wellington Management Group held 3,975,605 shares of Taysha Gene Therapies worth $27.1M as of Q2 2026.
  • Wellington Management Group bought 3,349,244 Taysha Gene Therapies shares in Q2 2026, an estimated $19.8M.
  • Taysha Gene Therapies made up ﹤0.01% of Wellington Management Group's portfolio in Q2 2026, its #945 holding.
  • Wellington Management Group first reported a position in Taysha Gene Therapies in Q3 2020 and has held it in 9 quarters since.
  • 209 funds tracked by Wall St. Rank held Taysha Gene Therapies as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.